Nanoformulations of doxorubicin: how far have we come and where do we go from here?
- 11 June 2018
- journal article
- review article
- Published by IOP Publishing in Nanotechnology
- Vol. 29 (33) , 332002
Abstract
Nanotechnology, focused on discovery and development of new pharmaceutical products is known as nanopharmacology, and one research area this branch is engaged in are nanopharmaceuticals. The importance of being nano has been particularly emphasized in scientific areas dealing with nanomedicine and nanopharmaceuticals. Nanopharmaceuticals, their routes of administration, obstacles and solutions concerning their improved application and enhanced efficacy have been briefly yet comprehensively described. Cancer is one of the leading causes of death worldwide and evergrowing number of scientific research on the topic only confirms that the needs have not been completed yet and that there is a wide platform for improvement. This is undoubtedly true for nanoformulations of an anticancer drug doxorubicin, where various nanocarrriers were given an important role to reduce the drug toxicity, while the efficacy of the drug was supposed to be retained or preferably enhanced. Therefore, we present an interdisciplinary comprehensive overview of interdisciplinary nature on nanopharmaceuticals based on doxorubicin and its nanoformulations with valuable information concerning trends, obstacles and prospective of nanopharmaceuticals development, mode of activity of sole drug doxorubicin and its nanoformulations based on different nanocarriers, their brief descriptions of biological activity through assessing in vitro and in vivo behavior.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (III45005)
This publication has 215 references indexed in Scilit:
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicinNature Communications, 2013
- Doxorubicin Enhances Nucleosome Turnover around PromotersCurrent Biology, 2013
- Polymer nanogels: A versatile nanoscopic drug delivery platformAdvanced Drug Delivery Reviews, 2012
- Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug releaseJournal of Controlled Release, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer ChemotherapyPharmaceutical Research, 2010
- Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug ReleaseACS Nano, 2010
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology2009
- Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer TherapyAngewandte Chemie International Edition, 2009
- Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cellsJournal of Controlled Release, 2007